How to buy Eledon Pharmaceuticals stock (ELDN)

Eledon Pharmaceuticals is a biotechnology business based in the US. Eledon Pharmaceuticals shares (ELDN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.36 – a decrease of 0.46% over the previous week. Eledon Pharmaceuticals employs 20 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Eledon Pharmaceuticals stock

Buy Eledon Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Eledon Pharmaceuticals stock price (NASDAQ: ELDN)

Use our graph to track the performance of ELDN stocks over time.

Eledon Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$4.36
52-week range	$1.43 - $5.54
50-day moving average more info button	$4.03
200-day moving average more info button	$2.84
Wall St. target price	$12.50
PE ratio more info button	5.726
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.73

Is it a good time to buy Eledon Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Eledon Pharmaceuticals price performance over time

Historical closes compared with the close of $4.18 from 2024-12-18

1 week (2024-12-13)	-4.57%
1 month (2024-11-21)	2.70%
3 months (2024-09-20)	57.74%
6 months (2024-06-21)	53.11%

1 year (2023-12-21)	182.43%
2 years (2022-12-21)	69.92%
3 years (2021-12-21)	4.48
5 years (2019-12-20)	11.34

Is Eledon Pharmaceuticals stock undervalued or overvalued?

Valuing Eledon Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Eledon Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Eledon Pharmaceuticals's P/E ratio

Eledon Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6x. In other words, Eledon Pharmaceuticals shares trade at around 6x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Eledon Pharmaceuticals financials

Gross profit TTM	$0
Return on assets TTM	-33.36%
Return on equity TTM	-25.36%
Profit margin	0%
Book value	$1.85
Market Capitalization more info button	$249.7 million

TTM: trailing 12 months

Eledon Pharmaceuticals share dividends

We're not expecting Eledon Pharmaceuticals to pay a dividend over the next 12 months.

Have Eledon Pharmaceuticals's shares ever split?

Eledon Pharmaceuticals's shares were split on a 1:18 basis on 4 October 2020 . So if you had owned 18 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Eledon Pharmaceuticals shares – just the quantity. However, indirectly, the new 1700% higher share price could have impacted the market appetite for Eledon Pharmaceuticals shares which in turn could have impacted Eledon Pharmaceuticals's share price.

Eledon Pharmaceuticals share price volatility

Over the last 12 months, Eledon Pharmaceuticals's shares have ranged in value from as little as $1.43 up to $5.54. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eledon Pharmaceuticals's is 0.766. This would suggest that Eledon Pharmaceuticals's shares are less volatile than average (for this exchange).

Eledon Pharmaceuticals overview

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for kidney transplantation, xenotransplantation, and liver transplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc.

Frequently asked questions

null
What percentage of Eledon Pharmaceuticals is owned by insiders or institutions?
Currently 0.043% of Eledon Pharmaceuticals shares are held by insiders and 42.877% by institutions. How many people work for Eledon Pharmaceuticals?
Latest data suggests 20 work at Eledon Pharmaceuticals. When does the fiscal year end for Eledon Pharmaceuticals?
Eledon Pharmaceuticals's fiscal year ends in December. Where is Eledon Pharmaceuticals based?
Eledon Pharmaceuticals's address is: 19900 MacArthur Boulevard, Irvine, CA, United States, 92612 What is Eledon Pharmaceuticals's ISIN number?
Eledon Pharmaceuticals's international securities identification number is: US28617K1016